查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1528102

3D 細胞培養的全球市場

3D Cell Culture
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 150 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球 3D 細胞培養市場將達到 39 億美元

2023 年全球 3D 細胞培養市場估計為 16 億美元，預計到 2030 年將達到 39 億美元，2023-2030 年分析期間複合年成長率為 13.9%。基於支架的 3D 細胞培養是本報告分析的細分市場之一，預計複合年成長率為 13.9%，到分析期結束時將達到 17 億美元。在分析期間，無支架 3D 細胞培養部分的複合年成長率估計為 13.3%。

美國市場預計將達到4.987億美元，中國預計複合年成長率為14.9%。

預計 2023 年美國3D 細胞培養市場規模將達 4.987 億美元。中國作為全球第二大經濟體，預計2030年市場規模將達2.488億美元，2023-2030年分析期間複合年成長率為14.9%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 12.5% 和 12.0%。在歐洲，德國的複合年成長率預計約為 16.4%。

全球3D細胞培養市場趨勢及促進因素總結

什麼是 3D 細胞培養？

3D細胞培養是生物醫學研究中的突破性技術，可在接近人體組織自然狀態的3D環境中培養細胞。與細胞在平皿中生長的傳統 2D 培養不同， 3D細胞培養允許細胞在各個方向上相互作用，對改善細胞生長、功能和對刺激的反應能力產生很大影響。此方法為研究複雜的生物過程、測試藥物和了解疾病進展提供了更準確的模型。一個主要應用是癌症研究，其中 3D 培養可以更真實地重建腫瘤微環境，並改善對癌細胞對治療的反應的預測。這項技術在組織工程、再生醫學和幹細胞研究中也至關重要，為治療方法治療方法的開發和測試提供了新的可能性。

科技進步如何增強 3D 細胞培養技術？

技術進步顯著提高了 3D 細胞培養系統的能力。支架材料和設計的創新至關重要，因為這些結構透過模仿自然組織中的細胞外基質來支持細胞生長。正在開發生物分解性和生物相容性材料，例如水凝膠、微圖案表面和奈米纖維支架，以提高細胞活力和功能。此外，3D細胞培養和微流體技術（晶片器官系統的基礎）的整合使得能夠模擬血流等生理條件，這對於創建準確的器官模型至關重要。成像技術和分析技術的進步也使研究人員能夠即時觀察和測量這些複雜的3D 結構內的細胞過程，從而使研究人員能夠研究細胞行為和藥物治療，而無需進行侵入性操作。了解您的反應。

3D 細胞培養將如何影響藥物開發和個人化醫療？

3D 細胞培養對藥物發現和個人化醫療的影響是重大且多方面的。在藥物發現中，3D 模型大大減少了對動物實驗的依賴，並提供了一種更符合倫理且更具成本效益的方式來篩檢潛在藥物。 3D 培養增強的生物學相關性使我們能夠更準確地預測藥物在人體臨床試驗中的作用，提高開發過程的效率並消除後期失敗的風險。在個人化醫療中，可以使用從個別患者中提取的細胞來開發 3D 培養物，使研究人員和臨床醫生能夠根據具體情況測試特定治療的效果。這種方法不僅可以根據個體的遺傳和生化背景制定治療方案，還能確定最有效的治療策略，最大限度地減少副作用，使患者免受無效治療的困擾。

3D細胞培養市場成長的驅動力是什麼？

3D細胞培養市場的成長受到多種因素的推動，包括對更準確、更可靠的藥物篩檢方法的需求不斷成長，以及對個人化醫療解決方案的需求不斷成長。增強 3D 培養系統的擴充性、可重複性和自動化的技術創新對於滿足這些需求至關重要。此外，隨著 3D 細胞培養在臨床應用中的潛力變得越來越清晰，製藥公司和醫療保健提供者對投資這項技術的興趣也越來越大。消費行為，特別是減少製藥和化妝品行業動物測試的社會和監管壓力的增加，也在推動 3D 文化的採用方面發揮關鍵作用。此外，3D細胞培養在癌症研究、幹細胞治療和組織工程中的不斷擴大應用繼續刺激該領域新產品和技術的開發。這些因素加上正在進行的學術和商業性研究合作，確保了一個充滿活力且不斷擴大的市場，有望解決醫學研究和患者護理中的一些最困難的問題。

受訪企業範例（共38家）

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • GE Healthcare
  • Corning, Inc.
  • Charles River Laboratories International, Inc.
  • BioTek Instruments, Inc.
  • F. Hoffmann-La Roche AG
  • AMS Biotechnology（Europe）Ltd.（amsbio）
  • BellBrook Labs
  • ABER Instruments Ltd.
  • Creative Biolabs
  • Elveflow
  • Emulate, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 世界其他地區

第4章 比賽

簡介目錄
Product Code: MCP10010

Global 3D Cell Culture Market to Reach US$3.9 Billion by 2030

The global market for 3D Cell Culture estimated at US$1.6 Billion in the year 2023, is expected to reach US$3.9 Billion by 2030, growing at a CAGR of 13.9% over the analysis period 2023-2030. Scaffold-based 3D Cell Culture, one of the segments analyzed in the report, is expected to record a 13.9% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Scaffold-free 3D Cell Culture segment is estimated at 13.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$498.7 Million While China is Forecast to Grow at 14.9% CAGR

The 3D Cell Culture market in the U.S. is estimated at US$498.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$248.8 Million by the year 2030 trailing a CAGR of 14.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.5% and 12.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 16.4% CAGR.

Global 3D Cell Culture Market - Key Trends & Drivers Summarized

What Is 3D Cell Culture and Why Is It Revolutionizing Biomedical Research?

3D cell culture is a groundbreaking technique in biomedical research that allows cells to grow in a three-dimensional environment, closely mimicking the natural conditions of human tissues. Unlike traditional 2D cultures where cells are grown in flat dishes, 3D cell cultures enable cells to interact in all directions, which significantly influences their growth, function, and responsiveness to stimuli. This method provides a more accurate model for studying complex biological processes, testing pharmaceuticals, and understanding disease progression. Key applications include cancer research, where 3D cultures replicate tumor microenvironments more realistically, enhancing the predictive accuracy of how cancerous cells respond to treatments. This technology is also pivotal in tissue engineering, regenerative medicine, and stem cell research, offering new potentials for developing and testing medical treatments and therapies.

How Are Technological Advancements Enhancing 3D Cell Culture Techniques?

Technological advancements are significantly enhancing the capabilities of 3D cell culture systems. Innovations in scaffold materials and design are crucial, as these structures support the growth of cells by mimicking the extracellular matrix found in natural tissues. Biodegradable and biocompatible materials such as hydrogels, micropatterned surfaces, and nanofiber scaffolds are being developed to improve cell viability and function. Additionally, the integration of microfluidics technology with 3D cell cultures—the basis of organ-on-a-chip systems—enables the simulation of physiological conditions, such as blood flow, which are essential for creating accurate organ models. Advances in imaging and analytical techniques also allow researchers to observe and measure cellular processes in real-time within these complex 3D structures, providing deeper insights into cellular behaviors and drug responses without the need for invasive procedures.

What Impact Does 3D Cell Culture Have on Drug Development and Personalized Medicine?

3D cell culture's impact on drug development and personalized medicine is profound and multifaceted. In drug discovery, 3D models significantly reduce the reliance on animal testing, providing a more ethical and cost-effective method for screening potential drugs. The enhanced biological relevance of 3D cultures leads to better prediction of how drugs will perform in human trials, thus improving the efficiency of the development process and reducing the risk of late-stage failures. For personalized medicine, 3D cultures can be developed using cells extracted from individual patients, allowing researchers and clinicians to test how specific treatments might work on a case-by-case basis. This approach not only tailors therapies to individual genetic and biochemical backgrounds but also helps in identifying the most effective treatment strategies, minimizing side effects, and sparing patients from ineffective treatments.

What Drives the Growth of the 3D Cell Culture Market?

The growth in the 3D cell culture market is driven by several factors, including the escalating demand for more accurate and reliable drug screening methods and the rising need for personalized medicine solutions. Technological innovations that offer enhanced scalability, reproducibility, and automation of 3D culture systems are crucial in meeting these demands. Additionally, as the potential of 3D cell cultures in clinical applications becomes more evident, there is a growing interest from pharmaceutical companies and healthcare providers to invest in this technology. Consumer behavior, particularly the increasing public and regulatory pressure to reduce animal testing in pharmaceutical and cosmetic industries, also plays a significant role in driving the adoption of 3D cultures. Moreover, the expanding applications of 3D cell cultures in cancer research, stem cell therapy, and tissue engineering continue to spur the development of new products and techniques in this field. These factors, combined with ongoing academic and commercial research collaborations, ensure a dynamic and expanding market, poised to address some of the most challenging issues in medical research and patient care.

Select Competitors (Total 38 Featured) -

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • GE Healthcare
  • Corning, Inc.
  • Charles River Laboratories International, Inc.
  • BioTek Instruments, Inc.
  • F. Hoffmann-La Roche AG
  • AMS Biotechnology (Europe) Ltd. (amsbio)
  • BellBrook Labs
  • ABER Instruments Ltd.
  • Creative Biolabs
  • Elveflow
  • Emulate, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • 3D Cell Culture - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • 3D Cell Culture Transforms Life Sciences Industry
    • 3D Cell Culture: An Introduction
    • 3D-Cell Culture Models
    • Benefits of 3D Cell Culture
    • Key 3D Cell Culture Formats
    • 3D Cell Culture-Different Techniques
    • Scaffold-Based 3D Cell Culture
    • Polymeric Hard Scaffolds
    • Biological Scaffolds
    • Micropatterned Surface Microplates
    • Non-Scaffold Based 3D Cell Culture
    • Hanging Drop Microplates
    • Spheroid Microplates with Ultra-Low Attachment (ULA) coating
    • Microfluidic 3D Cell Culture
    • Expanding Applications Fuel Growth in the Global 3D Cell Culture Market
    • Developed Regions Lead the 3D Cell Culture Market, Asia-Pacific to Register Faster Growth
    • Scaffold-based 3D Cell Culture Products Dominate the Market
    • Cancer and Stem Cell Research Leads the Global Market
    • Competitive Scenario
    • Key Commercial 3D Cell Culture Devices
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cancer Drives the Demand for 3D Cell Culture
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • Increasing Demand for 3D Cell Culture in Drug Discovery
    • Use of 3D Cell Culture for Regenerative Medicine
    • Organoids as Alternatives to Using Animals in Experiments
    • Use of 3D Cell Culture for Regenerative Medicine
    • Microfluidic Chips Hold Potential in Addressing 3D Cell Culture Challenges
    • Technological Advancements Promote 3D Cell Culture Market
    • Researchers Use Lab-on-a-CD Technology to Generate Spheroid 3D Cell Cultures
    • 3D Bioprinting Holds Potential to Revolutionize Organ Transplantation Space
    • A Review of Research Efforts and Achievements of Companies and Universities
    • 3D Tissue Culture: Growing Significance in Cancer Research
    • Cells Grown in 3D Change Cell Proliferation and Morphology
    • Cells Grown in 3D Demonstrate a More Pragmatic Drug Response
    • Cells Grown in 3D Express Phenotypic Heterogeneity
    • Cells Grown in 3D Alter Cell Behavior and Gene Expression
    • Cells Grown in 3D Replicate the Tumor Microenvironment
    • Other Advantages of 3D Tissue Culture Models
    • New Dimension of Cell Culture: The Rise of Spheroid Culture Systems
    • Challenges
    • Progress in Scaffolds and Hydrogels Aids Creation of Organoids and Spheroids
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for 3D Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for 3D Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 3: World 13-Year Perspective for 3D Cell Culture by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2017, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Scaffold-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Scaffold-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 6: World 13-Year Perspective for Scaffold-based by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Scaffold-free by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Scaffold-free by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 9: World 13-Year Perspective for Scaffold-free by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Microfluidics-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Microfluidics-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 12: World 13-Year Perspective for Microfluidics-based by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Magnetic & Bioprinted by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Magnetic & Bioprinted by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 15: World 13-Year Perspective for Magnetic & Bioprinted by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Cancer & Stem Cell Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Cancer & Stem Cell Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 18: World 13-Year Perspective for Cancer & Stem Cell Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Drug Discovery & Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Drug Discovery & Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 21: World 13-Year Perspective for Drug Discovery & Toxicology Testing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Tissue Engineering & Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Tissue Engineering & Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 24: World 13-Year Perspective for Tissue Engineering & Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2024 & 2030
    • TABLE 25: World 3D Cell Culture Market Analysis of Annual Sales in US$ Thousand for Years 2017 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • 3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 28: USA 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 31: USA 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 34: Canada 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 37: Canada 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
  • JAPAN
    • 3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 40: Japan 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 43: Japan 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
  • CHINA
    • 3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 46: China 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 49: China 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
  • EUROPE
    • 3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for 3D Cell Culture by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for 3D Cell Culture by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 52: Europe 13-Year Perspective for 3D Cell Culture by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2017, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 55: Europe 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 58: Europe 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
  • FRANCE
    • 3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 61: France 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 64: France 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
  • GERMANY
    • 3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 67: Germany 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 70: Germany 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 73: Italy 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 76: Italy 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
  • UNITED KINGDOM
    • 3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 79: UK 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 82: UK 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
  • REST OF EUROPE
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
  • ASIA-PACIFIC
    • 3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
  • REST OF WORLD
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 97: Rest of World 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 100: Rest of World 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030

IV. COMPETITION